Journey II Bi-Cruciate Stabilized (BCS) Total Knee System Retrospective Study

NCT03292003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1694

Last updated 2019-03-28

No results posted yet for this study

Summary

The objective of this study is to estimate the safety and performance of Journey II BCS TKS.

Conditions

  • Total Knee Arthroplasty

Interventions

DEVICE

Journey II BCS Total Knee System

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Beate Hanson, MD, PhD · Vice President, Global Clinical Strategy

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-30
Primary Completion
2018-01-30
Completion
2018-09-24
FDA Device
Yes

Countries

  • United States
  • Belgium
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03292003 on ClinicalTrials.gov